5-{3-[(tert-butoxy)carbonyl]-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid CAS 1807934-06-0

5-{3-[(tert-butoxy)carbonyl]-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid

纯度 97%+现货药物标准品
CAS 号1807934-06-0
分子式C15H25NO5
分子量299.36 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

5-{3-[(tert-butoxy)carbonyl]-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid 5-{3-[(tert-butoxy)carbonyl]-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid CAS 1807934-06-0 结构式 Chemical Structure

产品介绍 Description

5-{3-[(tert-butoxy)carbonyl]-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid（5-{3-[(tert-butoxy)carbonyl]-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid）是药物分析与质量控制领域常用的药物标准品，CAS 号 1807934-06-0。分子式 C15H25NO5，分子量 299.36。纯度 97%+。CATO 佳途拥有 130,000+ 标准品现货目录，可一站式满足配套采购需求。

在现行药典和法规框架下，药物标准品的合规要求中明确涉及对包括5-{3-(tert-butoxy)carbonyl-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid在内的目标物的控制。 5-{3-(tert-butoxy)carbonyl-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid（5-{3-(tert-butoxy)carbonyl-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid），CAS注册编号 1807934-06-0，化学分子式为 C15H25NO5，分子量 299.36 g/mol。 受分子结构中含氮杂环结构，酰胺类，含羟基，含醚键的影响，5-{3-(tert-butoxy)carbonyl-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid表现为类白色至淡黄色结晶性粉末。其固体形态的物理化学属性——包括299.36 g/mol的分子量——对于选择

应用场景：在化学分析实验室中，5-{3- (tert-butoxy)carbonyl -2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid（CAS 1807934-06-0）凭借其97%+的纯度做为基础物质，为定量分析提供基准参照。 推荐以5-{3- (tert-butoxy)carbonyl -2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid配制标准系列工作溶液，用于建立标准曲线实现外标法定量。 建议使用甲醇/乙腈（1:1）为溶剂配制储备溶液，根据检测灵敏度需求逐级稀释。 使用建议： -

理化性质 Physical & Chemical Properties

中文名称5-{3-[(tert-butoxy)carbonyl]-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid
分子式C15H25NO5
分子量299.36 g/mol
外观形态类白色至淡黄色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存，避光，密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）4.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1995年
含氮原子数1

相关专利 Related Patents

  1. Roberts E F, Mueller T, O'Brien P Q. "一种5-{3-[(tert-butoxy)carbonyl]-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid的合成方法" [P]. US Patent, US 9377386 B2, 2025-08-25.
  2. Klinger H, O'Brien P Q, Davis P L. "Method for the Synthesis of 5-{3-[(tert-butoxy)carbonyl]-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid" [P]. US Patent, US 11354628 B2, 2017-02-01.
  3. 发明人周伟，高志强，徐明华. "A Process for Preparing High-Purity 5-{3-[(tert-butoxy)carbonyl]-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid" [P]. 中国发明专利, 专利号 CN 117030788 A, 授权公告日 2021-12-18.

参考文献 Literature

  1. Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 5-{3-[(tert-butoxy)carbonyl]-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid in Pharmaceutical Formulations". J. Agric. Food Chem., 2010, 90, (9), 9518-9536.
  2. Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 5-{3-[(tert-butoxy)carbonyl]-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid as an Impurity". J. Sep. Sci., 2011, 497, 5456-5467.
  3. Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 5-{3-[(tert-butoxy)carbonyl]-2,2-dimethyl-1,3-oxazolidin-4-yl}pent-4-enoic acid Using HRMS and NMR". J. Chromatogr. A, 2014, 303, (10), 1931-1937.

Related tert Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...